13F-HR filed by SAMSARA BIOCAPITAL, LLC
SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 39 holding rows worth $646,373,019.
- Accession
- 0001104659-24-061946
- Filer
- CIK 1744967
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 39 entries on the cover page, a total value of $646,373,019 stated on the cover page (in dollars after the unit check, H1), rows summing to $646,373,019 with VALUE read as dollars as filed, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 6,788,609 | $120,565,696 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 4,121,689 | $91,996,098 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 5,074,916 | $65,517,166 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 1,267,790 | $64,530,511 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 3,768,035 | $40,732,458 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 453,641 | $31,550,732 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 1,208,473 | $26,985,202 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 2,780,261 | $17,293,223 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 2,523,022 | $17,030,399 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 967,527 | $16,341,531 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 525,000 | $15,414,000 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,458,875 | $15,347,365 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 799,274 | $13,291,927 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 850,000 | $12,155,000 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,562,500 | $11,968,750 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,786,427 | $9,557,384 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,675,579 | $9,467,021 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 172,647 | $7,480,795 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 6,130,268 | $7,233,716 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 180,207 | $6,784,794 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 3,640,015 | $6,297,226 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 347,500 | $5,591,275 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 630,000 | $5,002,200 | dollars as filed | |
| VTV THERAPEUTICS INC | 918385204 | CL A NEW | 206,784 | $4,865,628 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 396,000 | $4,161,960 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 291,666 | $4,124,157 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 540,304 | $3,782,128 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 196,425 | $3,244,941 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 669,303 | $1,780,346 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 154,664 | $1,492,508 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 1,049,153 | $1,468,814 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 202,348 | $1,327,403 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 696,171 | $863,252 | dollars as filed | |
| VIRACTA THERAPEUTICS INC | 92765F108 | COM | 689,709 | $703,503 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 172,089 | $216,832 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 78,131 | $101,570 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 82,336 | $62,155 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 133,333 | $40,333 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 99,999 | $3,020 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-061946 | this filing | 2024-05-15 | acceptance time not in the bulk data set |